Guia prático para o manejo da anafilaxia - 2012
Practical guide to the management of anaphylaxis - 2012
Luiz A. G. Bernd; Adriano B. de Sá; Alexandra S. Watanabe; Ana P. M. Castro; Dirceu Solé; Fábio M. Castro; Mario Geller; Regis A. Campos
Resumo
Anafilaxia representa uma das mais dramáticas condições clínicas da medicina, tanto pela imprevisibilidade de aparecimento quanto pelo potencial de gravidade na sua evolução. A ocorrência de anafilaxia determina enorme impacto na qualidade de vida das pessoas afetadas, dos seus familiares, cuidadores e amigos. As principais causas de anafilaxia são medicamentos, alimentos e veneno de insetos. Estudos epidemiológicos recentes sugerem aumento da incidência de anafilaxia. Aprofundar o conhecimento de causas e mecanismos de anafilaxia tem sido preocupação constante da especialidade de Imunoalergologia. Nos ambulatórios de Alergia e Imunologia Clínica são atendidas com regularidade pessoas que sofreram reações alergicas agudas graves e que necessitam de orientação especializada. Não é raro verificar que muitas superaram vários episódios agudos sem receber o diagnóstico correto, assim como a orientação específica para procurar atendimento especializado. Cada reação anafilática representa risco, que é variavel dependendo das caracteristicas do paciente e do agente desencadeante. A falta de informação de médicos e pacientes contribui para aumentar a chance de novas ocorrências, expondo estes a riscos muitas vezes preveníveis. O Guia Prático para o Manejo da Anafilaxia-2012 tem o objetivo de difundir o conhecimento sobre anafilaxia entre médicos e profissionais da saúde, pacientes, familiares, professores, escolas e autoridades de saúde pública. Este documento não é um protocolo de atendimento a pacientes com reações anafiláticas, nem pretende formular rotinas clínicas ou interferir na autonomia e no discernimento do médico ao avaliar e orientar pacientes que estão aos seus cuidados. O documento contém de forma muito concisa o conhecimento atual sobre o tema e a experiência pessoal de especialistas no manejo dessas situações, fornecendo informação para o aprimoramento pessoal. Aborda-se o diagnóstico e tratamento emergencial da anafilaxia, assim como, a avaliação e o tratamento após a crise. Cuidados básicos e atitudes preventivas que são fundamentais na orientação de pacientes e familiares são analisadas.
Palavras-chave
Abstract
Anaphylaxis is one of the most dramatic clinical conditions of Medicine, by the unpredictability of emergence and by the potential of severity in its evolution. Anaphylaxis determines an enormous impact on the quality of life of people affected, their families, caregivers and friends. The most frequent cause of anaphylaxis are drugs, foods, and stinging insect venoms. Recent epidemiological surveys have suggested increased incidence of anaphylaxis. Development of the knowledge of the causes and mechanisms of anaphylaxis has been a constant concern of the specialist of Immunoallergology. In Allergy and Clinical Immunology clinics are frequent to consult people who have suffered severe acute allergic reactions that require expert guidance. Many patients had suffered previous episodes without receiving the correct diagnosis as well as specific guidance to seek specialized care. Each allergic crisis represents a health risk, which is variable depending on the characteristics of the patient and the triggering agent. The lack of information from doctors and patients contributes to increase the chance of new episodes, exposing patients to preventable risk. The Practical Management of Anaphylaxis-2012 aims to spread knowledge of anaphylaxis among physicians, healthcare professionals, patients, families, teachers, schools, and public health authorities. This document is not a protocol of care to patients with anaphylactic reactions, nor is it intended to formulate practical clinical routines and, its objective should not interfere with the autonomy and the discernment of the physician to evaluate and treat patients who are to their care. The document contains very concisely the current knowledge about the subject and the personal experience of specialists in the management of these situations, providing information for personal improvement. Deals with the diagnosis and emergency treatment of anaphylaxis, as well as the assessment and treatment after the crisis. Basic and preventive care who are fundamental attitudes for patients and families are analyzed.
Keywords
References
1. Bansal PJ, Marsh R, Patel B, Tobin MC. Recognition, evaluation, and treatment of anaphylaxis in the child care setting. Ann Allergy Asthma Immunol 2005;94:55-9.
2. Ben-Shoshan M, Clarke A.E. Anaphylaxis: past, present and future. Allergy 2011;66:1-14.
3. Bernd LAG, Fleig FM, Alves MB, Bertozzo R, Coelho M, et al. Anafilaxia no Brasil - Levantamento da ASBAI. Rev bras alerg imunopatol 2010;33:190-8.
4. Bernd LA, Solé D, Pastorino AC, Prado EA, Castro FM, Rizzo MC, et al. Anafilaxia: guia prático para o manejo. Rev bras alerg imunopatol 2006;29(6):283-91.
5. Blanco C. Latex-fruit syndrome. Curr Allergy Asthma Rep 2003;3(1):47-53.
6. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007;119(4):1016-8.
7. Brockow K, Ring J. Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol 2011;11:326-31.
8. Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind placebo-controlled crossover trial. Lancet 2003;361:1001-6.
9. Campbell RL, Luke A, Weaver AL, St Sauver JL, Bergstralh EJ, Li JT, et al. Prescriptions for self-injectible epinephrine and follow up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008;101:631-6.
10. Chacko T, Ledford D. Peri-anesthetic anaphylaxis. Immunol Allergy Clin N Am 2007;27:213-30.
11. Chapman JA, Bernstein L, Lee RE, American College of Allergy, Asthma, & Immunology. Food allergy: a practice parameter. Ann Allergy Asthma Immunol 2006;96(3 Suppl 2):S1-68.
12. Choo K, Sheikh A. Action plans for the long-term management of anaphylaxis: systematic review of effectiveness. Clin Exp Allergy 2007;37(7):1090-4.
13. Condemi JJ. Allergic reactions to natural rubber latex at home, to rubber products, and to cross-reacting foods. J Allergy Clin Immunol 2002;110(2):S107-10.
14. Dolen WK. IgE antibody in the serum – detection and diagnostic significance. Allergy 2003:58:717-25.
15. Ebo DG, Fischer MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007;62:471-87.
16. Eigenmann PA, Oh JW, Beyer K. Diagnostic testing in the evaluation of food allergy. Pediatr Clin North Am 2011;58(2):351-62.
17. Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2009;40:15-31.
18. FAAN. The Food Allergy and Anaphylaxis Network. Disponível em: www.foodallergy.org. Acessado em 12 de janeiro de 2012.
19. Frew AJ. What are the ideal features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? Allergy 2011;66:15‑24.
20. Gaspar A, Pires G, Matos V, Loureiro V, Almeida MM, Pinto JR. Prevalence and risk factors for latex-fruit syndrome in patients with latex allergy. Rev Port Imunoalergol 2004;XII:209-23.
21. Geller M. Anafilaxia idiopática em criança. Rev bras alerg imunopatol 2004;27:76-9.
22. Geller M. Anafilaxia induzida por exercício com dependência alimentar. JBM 1993.
23. Golden DB. Insect Sting anaphylaxis. Immunol Allergy Clin North Am 2007;27:261-72.
24. Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter: update 2011. J Allergy Clin Immunol 2011;127:852-4.
25. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2007;27:273-93.
26. Gruchalla RS. 10-Drug Allergy. J Allergy Clin Immunol 2003;111:S548-59.
27. Jacob CM, Castro AP, Yonamine GH, Souza FF, Brandão AC, Ribeiro LA. Alergia Alimentar. In Jacob CM, Pastorino AC, Schwartsman BS, Maluf Jr PT Alergia e Imunologia para o Pediatra– 2a ediçãoBarueri, SP Manole 2010, p289-313.
28. Kemp AS. Action on anaphylaxis action plans. J Paediatr Child Health 2010;46:554-6.
29. Kemp SF, Lockey RF, Fimons FER. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. WAO Journal 2008;S18-26.
30. Khan DA, Solensky R. Drug Allergy. J Allergy Clin Immunol 2010;125:S126-37.
31. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011;41:923-38.
32. Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstaein IL, Nicklas RA, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immnunol 2005;115:S483-523.
33. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM. The diagnosis and management of anaphylaxis practice parameter:
2010 Update. J Allergy Clin Immunol 2010;126:477-80.
34. Macy E. Multiple antibiotic allergy syndrome. Immunol Allergy Clin N Am 2004;24:533-43.
35. Mertes PM, Lambert M, Guéant-Rodriguez RM, Aimone-Gastin I, Mouton-Faivre C, Moneret-Vautrin DA, et al. Perioperative anaphylaxis. Immunol Allergy Clin N Am 2009;29:429-51.
36. Mertes PM, Lambert M, Regnier MA, Guéant-Rodriguez RM, Aimone-Gastin C, Moutin-Faivre D, et al. What investigation should be undertaken when faced with worsening perioperative anaphylaxis? Rev Fr Allerg 2009;49:437-42.
37. Mertes PM, Laxenaire MC, Lienhart A. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Invest Allergol Clin Immunol 2005;15:91-101.
38. Mertes PM, Tajima K, Regnier-Kimmoun MA, Lambert M, Iohom G, Guéant-Rodriguez RM, et al. Perioperative anaphylaxis. Med Clin N Am 2010;94:761-89.
39. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, Friedmann PS, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2008;39:43-61.
40. Moffitt JE, Golden DB, Reisman RE, Lee R, Nicklas R, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol 2004;114: 869-86.
41. Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lødrup Carlsen KC, et al. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Allergy 2010;1;65(6):681-9.
42. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2007:62:857-71.
43. Muraro A, Roberts G, Simons F. New visions for anaphylaxis: an iPAC summary and future trends. Pediatr Allergy Immunol 2008;19(Suppl 19):40-50.
44. Murphy KR, Hopp RJ, Kittelson EB, Hansen G, Windle ML, Walburn JN. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 2006;96:398-405.
45. Myorga C, Sanz ML, Gamboa PM, Garcia BE. In vitro diagnosis of immediate allergic reactions to drugs: an update. J Invest Allergol Clin Immunol 2010;20:103-9.
46. Pastorino AC, Rizzo MC, Rubini N, Di Gesu RW, Di Gesu GMS, Rosário Filho N, et al. Projeto Diretrizes (AMB/CFM). Anafilaxia: Diagnóstico. Disponível em: http://www.projetodiretrizes.org.br/diretrizes11/anafilaxia_diagnostico.pdf
47. Pastorino AC, Rizzo MC, Rubini N, Di Gesu RW, Di Gesu GMS, Rosário Filho N, et al. Projeto Diretrizes (AMB/CFM). Anafilaxia: Tratamento. Disponível em: http://www.projetodiretrizes.org.br/diretrizes11/anafilaxia_tratamento.pdf
48. Peters AT, Kim JS. Principles of evaluation and treatment: diagnosis of immediate hypersensitivity. In: Patterson’s Allergic Diseases, 7th ed., Grammer LC and Greenberger PA (ed), Philadelphia, Lippincott Williams & Wilkins: 123-135, 2009.
49. Pongracic JA, Kim JS. Update on epinephrine for the treatment of anaphylaxis. Curr Opin Pediatr 2007;19:94-8.
50. Portnoy JM, Amado M. Evidence-based Allergy Diagnostic Tests. Curr Allergy Asthma Rep 2006;6:455-61.
51. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4:285-90.
52. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003;112:451-2.
53. Quadros-Coelho M A, Coelho-Filho RM, Coelho AM, Alencar GG, Marques PQ, Solé D. Reações anafiláticas em serviço de urgência: tratamento farmacológico em 61 pacientes. Rev bras alerg imunopatol 2010;33(5):199-202.
54. Rawas-Qalaji M, Simons FER, Collins D, Simons RJ. Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis. Ann Allergy Asthma Immunol 2009;102:500-3.
55. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2006;117:391-7.
56. Boyce JA, Assaad A, Burks WA, Jones SM, Sampson HA, Wood RA, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID Sponsored Expert Panel Report. J Allergy Clin Immunol 2010;126:1105‑18.
57. Schiavino D, Nucera E, Roncalo C, Pollastrini E, De Pasquale, T, Lombardo C, et al. Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests. Ann Allergy Asthma Immunol 2007;99:136-42.
58. Schnyder B. Approach to the patient with drug allergy. Med Clin N Am 2010; 94:665-79.
59. Shadick NA, Liang MH, Partridge AJ, Bingham C, Wright E, Fossel AH, et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol 1999;104:123-7.
60. Sheikh A, Shehata YA, Brown SG, Simons FER. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2009;64:204-12.
61. Sicherer SH, Mahr T and the Section on Allergy and Immunology. Clinical report- management of food allergy in the school setting. Pediatrics 2010;126:1232-38.
62. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007;120(1 Suppl):S2‑24.
63. Simons FE. Anaphylaxis pathogenesis and treatment. Allergy 2011;66(suppl 95):31-4.
64. Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, et al. World Allergy Organization anaphylaxis guidelines: Summary. J Allergy Clin Immunol 2011;127:587‑93.
65. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD. Risk assessment in anaphylaxis: Current and future approaches. J Allergy Clin Immunol 2007;120:S2-24.
66. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998;101:33-7.
67. Simons FE. Anaphylaxis in infants: Can recognition and management be improved? J Allergy Clin Immunol 2007;120:537‑40.
68. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010;125(Suppl 2):S161-81.
69. Simons FE. Pharmacologic treatment of anaphylaxis: can the evidence base be strengthened? Curr Opin Allergy Clin Immunol 2010;10:384-93.
70. Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010;10:354‑61.
71. Sole D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LR, et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics (Sao Paulo) 2011;66(6):943-7.
72. Solensky R, Khan DA, Bernstein IL, Bloomberg GL, Castells MC, Mendelson LM, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010;105:259-73.
73. Steinman HA. “Hidden” allergens in foods. J Allergy Clin Immunol 1996;98(2):241-50.
74. Tramer MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 2006;333:675.
75. Weissman DN, Lewis DM. Allergic and latex-specific sensitization: route, frequency, and amount of exposure that are required to initiate IgE production. J Allergy Clin Immunol 2002;110:S57‑63.
Submitted date:
02/22/2012
Accepted date:
03/01/2012
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email